Implantable cardioverter defibrillator system having independently controllable electrode discharge pathway

Claim 3

The method of claim 1 wherein steps (b)-(d) are programmable for at least one cardioversion/defibrillation countershock at the time the implantable cardioversion defibrillation system is implanted.

Claim 4

The method of claim 2 further comprising: e) selectively reprogramming steps (b)-(d) after the implantable cardioversion system has been implanted.

Claim 5

The method of claim 2 further comprising: e) selectively programming steps (b)-(d) for a subsequent cardioversion/defibrillation countershock different than the programming for steps (b)-(d) for an initial cardioversion/defibrillation countershock.

Claim 6

An implantable cardioverter defibrillator system for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: at least three implantation electrodes for implantation in the patient in which the at least three implantation electrodes comprise two intravascular electrodes for implantation within the heart and one electrode for implantation in the subcutaneous space proximate to the heart; an implantable housing to which the implantation electrodes are electrically connected, the implantable housing including: capacitor means for storing an electrical charge; means for charging the capacitor means to produce the electrical charge; and means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: switch means for each implantation electrode for selectively electrically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode; and control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 7

An implantable cardioverter defibrillator system for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: at least three implantation electrodes for implantation in the patient in which the at least three implantation electrodes comprise two intravascular electrodes for implantation within the heart and one electrode for implantation in the subcutaneous space proximate to the heart; an implantable housing to which the implantation electrodes are electrically connected, the implantable housing including: capacitor means for storing an electrical charge; means for charging the capacitor means to produce the electrical charge; and means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: switch means for each implantation electrode for selectively electrically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode; and control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 8

The system of claim 5 in which the switch means for each implantation electrode comprises a silicon controlled rectifier switch and an insulated gate bipolar transistor switch.

Claim 9

The system of claim 6 in which the control means comprises polarity control means for controlling the polarity of the countershock waveform by closing only one of either the silicon controlled rectifier switch and the insulated gate bipolar transistor switch.

Claim 10

The system of claim 7 in which the polarity control means comprises phase control means for controlling the phase of the countershock waveform by first closing one of either the silicon controlled rectifier or insulated gate bipolar transistor switches, leaving the other switch open, then reversing switch configurations during delivery of the countershock waveform.

Claim 11

The system of claim 8 in which the control means comprises delay means for simultaneously controlling the switch means by independently opening or closing each pair of switches positioned within each switch means so as to configure a desired delay in transition of the phase or the polarity of the waveform.

Claim 12

The system of claim 5 in which the at least three implantation electrodes comprise a right supraventricular electrode, a right ventricular electrode, and the implantable housing.

Claim 13

The system of claim 5 in which the control means comprises re-programming means for re-programming the control means after implantation of the apparatus.

Claim 14

The system of claim 5 in which the control means comprises: logic means, responsive to the sensing of myocardial dysrhythmias, for determining that a cardioversion/defibrillation has been attempted and there is a continued sensing of a myocardial dysrhythmia and providing an unsuccessful attempt signal; and programming means, responsive to the presence of the unsuccessful attempt signal, for providing an initial discharge sequence settings program so that the one or more selective discharge pathways are controlled to respond to the continued sensing of the myocardial dysrhythmia according to an initial response setting and the one or more selective discharge pathways are altere according to the initial discharge sequence settings program for subsequent cardioversion/defibrillation waveforms discharged in the event that the initial response setting for a cardioversion/defibrillation waveform did not successfully treat the myocardial dysrhythmias.

Claim 15

An implantable cardioverter defibrillator apparatus for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: at least three implantation electrodes for implantation in the patient; an implantable housing to which the implantation electrodes are electrically connected, the implantable housing including: capacitor means for storing an electrical charge; means for charging the capacitor means to produce the electrical charge; and means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: switch means for each implantation electrode for selectively electerically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode in which each switch means comprises a silicon controlled rectifier switch and an insulated gate bipolar transistor switch; and control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 16

An implantable cardioverter defibrillator apparatus for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: at least three implantation electrodes for implantation in the patient; an implantable housing to which the implantation electrodes are electrically connected, the implantable housing including: capacitor means for storing an electrical charge; means for charging the capacitor means to produce the electrical charge; and means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: switch means for each implantation electrode for selectively electerically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode in which each switch means comprises a silicon controlled rectifier switch and an insulated gate bipolar transistor switch; and control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 17

The system of claim 13 in which the at least three implantation electrodes includes two intravascular electrodes for implantation within the heart and one electrode for implantation in the subcutaneous space proximate to the heart.

Claim 18

The system of claim 14 in which the electrode for implantation in the subcutaneous space is the implantable housing.

Claim 19

The system of claim 13 in which the control means comprises polarity control means for controlling the polarity of the countershock waveform by closing only one of either the silicon controlled rectifier switch and the insulated gate bipolar transistor switch.

Claim 20

The system of claim 16 in which the polarity control means comprises phase control means for controlling the phase of the countershock waveform by first closing one of either the silicon controlled rectifier or insulated gate bipolar transistor switches, leaving the other switch open, then reversing switch configurations during delivery of the countershock waveform.

Claim 21

The system of claim 17 in which the control means comprises delay means for simultaneously controlling the switch means by independently opening or closing each pair of switches positioned within each switch means so as to configure a desired delay in transition of the phase or the polarity of the waveform.

Claim 22

The system of claim 13 in which the control means comprises re-programming means for re-programming the control means after implantation of the apparatus.

Claim 23

The system of claim 13 in which the control means comprises: logic means, responsive to the sensing of myocardial dysrhythmias, for determining that a cardioversion/defibrillation has been attempted and there is a continued sensing of a myocardial dysrhythmia and providing an unsuccessful attempt signal; and programming means, responsive to the presence of the unsuccessful attempt signal, for providing an initial discharge sequence settings program so that the one or more selective discharge pathways are controlled to respond to the continued sensing of the myocardial dysrhythmia according to an initial response setting and the one or more selective discharge pathways are altered according to the initial discharge sequence settings program for subsequent cardioversion/defibrillation waveforms discharged in the event that the initial response setting for a cardioversion/defibrillation waveform did not successfully treat the myocardial dysrhythmias.

Claim 24

An implantable cardioverter defibrillator apparatus for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: a) at least three implantation electrodes for implantation in the patient in which the at least three implantation electrodes comprise a right supraventricular electrode, a right ventricular electrode, and a pacing/sensing electrode; b) capacitor means for storing an electrical charge; c) means for charging the capacitor means to produce the electrical charge; and d) means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: d1) switch means for each implantation electrode for selectively electrically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode; and d2) control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 25

An implantable cardioverter defibrillator apparatus for generating and delivering cardioversion or defibrillation countershocks of greater than about 0.1 joules to a human patient in response to a sensing of a myocardial dysrhythmia in the patient, comprising: a) at least three implantation electrodes for implantation in the patient in which the at least three implantation electrodes comprise a right supraventricular electrode, a right ventricular electrode, and a pacing/sensing electrode; b) capacitor means for storing an electrical charge; c) means for charging the capacitor means to produce the electrical charge; and d) means for selectively controlling a discharge of the electrical charge stored in the capacitor means in response to the sensing of the myocardial dysrhythmia to generate a cardioversion/defibrillation countershock waveform, including: d1) switch means for each implantation electrode for selectively electrically connecting the implantation electrode to either polarity of the capacitor means independent of the switch means for any other implantation electrode; and d2) control means for selectively controlling all of the switch means to create in response to the sensing of the myocardial dysrhythmia one or more selected discharge pathways through which to deliver all or part of the waveform.

Claim 26

The apparatus of claim 21 in which the at least three implantation electrodes includes two intravascular electrodes for implantation within the heart and one electrode for implantation in the subcutaneous space proximate to the heart.

Claim 27

The apparatus of claim 21 in which the switch means for each implantation electrode comprises a silicon controlled rectifier switch and an insulated gate bipolar transistor switch.

Claim 28

The apparatus of claim 21 in which the control means comprises polarity control means for controlling the polarity of the countershock waveform by closing only one of either the silicon controlled rectifier switch and the insulated gate bipolar transistor switch.

Claim 29

The apparatus of claim 24 in which the polarity control means comprises phase control means for controlling the phase of the countershock waveform by first closing one of either the silicon controlled rectifier or insulated gate bipolar transistor switches, leaving the other switch open, then reversing switch configurations during delivery of the countershock waveform.

Claim 30

The apparatus of claim 25 in which the control means comprises delay means for simultaneously controlling the switch means by independently opening or closing each pair of switches positioned within each switch means so as to configure a desired delay in transition of the phase or the polarity of the waveform.

Claim 31

The apparatus of claim 21 in which the control means comprises re-programming means for re-programming the control means after implantation of the apparatus.

Claim 32

The apparatus of claim 21 in which the control means comprises: logic means, responsive to the sensing of myocardial dysrhythmias, for determining that a cardioversion/defibrillation has been attempted and there is a continued sensing of a myocardial dysrhythmia and providing an unsuccessful attempt signal; and programming means, responsive to the presence of the unsuccessful attempt signal, for providing an initial discharge sequence settings program so that the one or more selective discharge pathways are controlled to respond to the continued sensing of the myocardial dysrhythmia according to an initial response setting and the one or more selective discharge pathways are altere according to the initial discharge sequence settings program for subsequent cardioversion/defibrillation waveforms discharged in the event that the initial response setting for a cardioversion/defibrillation waveform did not successfully treat the myocardial dysrhythmias.